Updated July 29, 2026. Quick answer: An exchange fund defers the gain under IRC §721(a). It does not erase it. Your low basis carries into the partnership interest, so the same gain is waiting whenever that interest is finally disposed of. What you have bought is time and diversification; what you have sold is liquidity and control. Selling and paying the tax is the only route that ends the exposure, and it belongs in the comparison as the baseline.
The framing error that drives most of these decisions
The instinct is to treat the tax on a sale as a loss and the exchange fund as the way to avoid it. That is not what §721(a) does. It says “No gain or loss shall be recognized” on the contribution — recognised, not eliminated. The basis travels. So the honest comparison is not tax versus no tax; it is pay now and be free versus pay later and accept the constraints in between.
| Sell now | Exchange fund | |
|---|---|---|
| Gain | Recognised now, ends the exposure | Deferred under §721(a); basis carries over |
| Proceeds | Cash, immediately, unrestricted | A partnership interest, not cash |
| Diversification | Total, and you choose it | Into whatever the fund pooled |
| Exit | Already done | In-kind redemption inside seven years accelerates gain under §737 |
| Who has to keep qualifying | Nobody | The fund, against Treas. Reg. §1.351-1(c) |
| Estate outcome | You hold cash or a chosen portfolio | You hold an illiquid partnership interest |
Where the fund genuinely wins. If the position is large enough that selling it is itself a market event, if the gain is a large fraction of the position, and if the money is not needed for a long horizon, deferral compounds on a bigger base and diversification arrives without a taxable event. Those conditions are real and they are the reason the product exists.
Where selling quietly wins. If the embedded gain is a modest share of the position, the deferral is small and you have paid for it with seven years of illiquidity, fund-level fees, and a portfolio someone else assembled. Tranched selling over several tax years is unglamorous, has no qualification risk, no counterparty, and no exit rule — and for a lot of holders it is simply the better trade.
The two questions to answer before the product conversation
First: what fraction of the position is gain? That single number decides how much deferral is actually being purchased. Second: is there any chance the money is needed inside seven years? If the answer is yes, §737 prices that exit and the calculation has to include it.
If the goal is to reduce risk rather than to diversify permanently, a collar is a different instrument on a different axis and does not require giving up the shares at all.
Sources
IRC §721(a) and §721(b); IRC §351(e)(1); Treas. Reg. §1.351-1(c)(1), (c)(2) and (c)(3); IRC §737(a) and §737(b)(1); IRC §704(c)(1)(B). All read July 2026.
This states what the cited authority says. It is not tax or legal advice. Constructive-sale analysis, partnership nonrecognition and insider-trading defences all turn on transaction documents and facts that no page can see, and the instruments described here are executed under contracts whose terms vary by provider.